Form 4 for DVA DaVita
Accepted 2025-03-18 00:00:00 ET · period of report 2025-03-15 · accession 0000927066-25-000069 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-03-18 | 2025-03-15 | DVA | Rodriguez Javier | CEO, Dir | A - Grant | $0.00 | +18.8K | 894.1K | +2% | $0 |
| D | 2025-03-18 | 2025-03-15 | DVA | Rodriguez Javier | CEO, Dir | A - Grant | $0.00 | +52.1K | 52.1K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-03-15 | A | A | 18,822 | $0.00 | 894,080 | D | — | — | (F1) These restricted stock units are scheduled to vest 50% each on March 15, 2028 and March 15, 2029, respectively, subject to the terms and conditions of the applicable award agreement. |
| 2 | Derivative | Stock Appreciation Rights | 2025-03-15 | A | A | 52,106 | $0.00 | 52,106 | D | $143.45 · 2028-03-15 to 2030-03-15 | 52,106 Common Stock | (F2) The stock appreciation rights are scheduled to vest 50% each on March 15, 2028 and March 15, 2029, respectively, subject to the terms and conditions of the applicable award agreement. |